Authors: Lauren Pulling, Editor
Today marks World MS Day, a day to bring the global multiple sclerosis (MS) community together to raise awareness, celebrate pioneering research, and look ahead to the future. Take a look at our selection of the latest highlights in MS research and check out our quickfire interviews with two key opinion leaders – Katerina Akassoglou (Gladstone Institutes, CA, USA) and Jeffrey Cohen (Cleveland Clinic, OH, USA) – to hear their views on the latest research and future trends.
The past 6 months have brought a number of significant developments in both our understanding of and treatments for MS; from the latest data for ocrelizumab to a new treatment targeting Epstein-Barr virus-infected B cells to combat the disease. But what do international experts think? Click on the interviews below to hear more from Neuro Central authors Katerina Akassoglou and Jeffrey Cohen, who discuss their thoughts on their biggest news in MS and what the future may hold. You can also find our top ten MS features from the year so far below.
MS highlights from the year so far…
- NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus
- New research takes us a step forward in the fight to understanding multiple sclerosis
- IL4I1 decreases inflammation and promotes CNS repair in models of multiple sclerosis
- Can we harness the CNS remyelination process to treat MS?
- Predicting disability outcomes in the modern era of multiple sclerosis treatment
- Neuroimmunology and multiple sclerosis: an interview with Katerina Akassoglou
- Antibody show promise against multiple sclerosis – the latest ocrelizumab data
- Alternative MRI contrast agent may reduce gadolinium brain deposits in multiple sclerosis patients
- NCTalks with Jeffrey Cohen: bone marrow transplantation for multiple sclerosis
- Cognitive impairment in multiple sclerosis: a matter of connectivity?